Floatz logo

Adezunap

Pain

Apurano Pharmaceuticals GmbHPhase 3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
81/ 100

Competitive context

43 Active assets in the Pain cohort.

Asset / SponsorPhaseRating
NEPENTHE
Bursa City Hospital
Phase 4BBB
Tapentadol
Grünenthal GmbH
Phase 4BBB
Oxycodone
The First Affiliated Hospital with Nanjing Medical University
Phase 4BBB
FENTANYL
Aga Khan University
Phase 4BBB
Nabiximols
Jazz Pharmaceuticals
Phase 3BBB

View all 50 →

Same molecule, other indications

Adezunap is also rated in:

Pain SyndromeDormant
B
Indicative ·
60 / 100
View asset →
Post Operative PainDormant
B
Indicative ·
60 / 100
View asset →
Central Neuropathic PainDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →